Bird Flu Vaccine Could Be Industrially Produced By February
According to the current tests a vaccine to prevent bird flu could be mass produced by February or March of next year, the director of the Russian Flu Research Center said Monday.
The strain of the virus obtained by reverse genetics (the process of introducing mutations into a cloned DNA segment to investigate gene function) using a Vietnamese avian flu isolate and the vaccine testing program developed by the Flu Research Center, have been passed on to the Tarasevich State Monitoring Institute.
To conclude this work effectively and obtain our own strain of the avian flu virus using Siberian isolates, needs sufficient financing to keep up the work rate.
You may also like to read
- Ten Years to Develop an Effective Bird Flu Vaccine
- China Would Soon Being Testing Bird Flu Vaccine
- Bird Flu Vaccine for Humans is Not Difficult, Says, Leading Vaccine Producer
- Bird Flu Vaccine : Latest Review
- Oral Bird Flu Vaccine from Russia
- UK 'Developing Bird Flu Vaccine'
- Bird Flu Vaccine 'Encouraging'
- Bird Flue Situation of UK is Directly Linked to Hungary ?
- New bird flu vaccine could be used to protect multiple animal species: assured USA scientists
- What is the Status of a Vaccine Against Bird Flu for Humans?
